Protagonist Therapeutics (PTGX) Financials: Revenue & Earnings

PTGX price $141.40 +0.28 +0.20%

Ticker
PTGX
Price
$141.40
Change
+0.28 +0.20%
Market cap ?
$9.15B
P/E ?
115.20
Forward P/E ?
30.12
Dividend yield ?
0.00%
Beta ?
1.79
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
55
Value
15
Quality
65
Growth
86

Stocklytics score rationale: value 15, quality 65, growth 86.

Financials

2016201720182019202020212022202320242025
020063000309250002310002862800027357000265810006000000043443300046016000

Protagonist Therapeutics, Inc. is a biopharmaceutical firm dedicated to discovering and advancing peptide-based therapies. Their research primarily focuses on treatments for hematological and blood conditions, as well as inflammatory and immune-mediated disorders. The company's pipeline features rusfertide (PTG-300), an injectable hepcidin mimetic currently undergoing Phase II clinical trials for the management of…

Fair value

PTGX fair value $110.49. Price $141.40. Price is 28% above fair value.

Above fair value, around its usual premium.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare PTGX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—2.50—238.48M
2026-08-052.292.23213.47M198.66M
2026-05-050.05-0.6556.37M11.70M
2026-02-25-0.69-0.537.44M8.74M
2025-11-06-0.62-0.594.71M14.92M
2025-08-06-0.55-0.535.55M8.43M
2025-05-06-0.19-0.5028.32M6.56M
2025-02-211.980.06170.64M81.01M
2024-11-07-0.54-0.594.67M38.81M
2024-08-06-0.50-0.504.17M8.00M
2024-05-073.261.19254.95M120.00M
2024-02-270.440.0360.00M40.00M
2023-11-02-0.58-0.68—38.33M
2023-08-03-0.68-0.65—8.33M
2023-05-04-0.67-0.69—2.00M
2023-03-15-0.69-0.67—5.00M
2022-11-08-0.64-0.94——
2022-08-04-0.84-0.99859.00K460.00K
2022-05-04-0.43-0.6725.72M21.18M
2022-02-28-0.77-0.798.62M5.07M
2021-11-03-0.70-0.6710.29M2.03M
2021-08-04-0.69-0.622.27M5.17M
2021-05-04-0.54-0.576.19M3.12M
2021-03-10-0.48-0.475.65M—
2020-11-04-0.21-0.6113.11M9.44M
2020-08-06-0.59-0.576.22M6.01M
2020-05-07-0.72-0.643.65M3.50M
2020-03-10-0.63-0.642.72M2.81M
2019-11-06-0.61-0.754.14M4.82M
2019-08-07-1.18-0.278.19M1.94M
2019-05-08-0.58-0.651.56M1.59M
2019-03-12-0.57-0.422.35M1.94M
2018-11-06-0.38-0.406.12M5.96M
2018-08-07-0.41-0.3011.67M9.97M
2018-05-09-0.36-0.2410.78M8.68M
2018-03-07-0.15-0.3611.28M26.32M
2017-11-06-0.29-0.958.78M21.50M
2017-08-08-0.89-0.92——
2017-05-10-0.84-0.64——
2017-03-07-0.67-0.52——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-09-30Ali AsifBuy5.31K$12.1764.65K
2026-09-30Ali AsifBuy15.65K$19.19300.32K
2026-09-30Ali AsifSell12.60K$141.771.79M
2026-09-30Ali AsifBuy28.44K$23.42666.02K
2026-09-30Ali AsifBuy9.23K$38.98359.75K
2026-09-30Ali AsifSell46.03K$141.786.53M
2026-09-30Ali AsifSell15.65K$19.19300.32K
2026-09-30Ali AsifSell28.44K$23.42666.02K
2026-09-30Ali AsifSell9.23K$38.98359.75K
2026-09-30Ali AsifSell5.31K$12.1764.65K
2026-09-10PATEL DINESH V PH DBuy7.28K$21.58157.06K
2026-09-10PATEL DINESH V PH DSell7.28K$144.101.05M
2026-09-10PATEL DINESH V PH DSell7.28K$21.58157.06K
2026-09-09PATEL DINESH V PH DBuy63.55K$21.581.37M
2026-09-09PATEL DINESH V PH DSell63.55K$146.189.29M
2026-09-09PATEL DINESH V PH DSell63.55K$21.581.37M
2026-09-08PATEL DINESH V PH DBuy54.17K$21.581.17M
2026-09-08PATEL DINESH V PH DSell54.17K$145.877.90M
2026-09-08PATEL DINESH V PH DSell54.17K$21.581.17M
2026-09-03PATEL DINESH V PH DSell510——
2026-08-11PATEL DINESH V PH DBuy34.24K$21.58738.88K
2026-08-11PATEL DINESH V PH DSell34.24K$148.525.09M
2026-08-11PATEL DINESH V PH DSell34.24K$21.58738.88K
2026-08-10PATEL DINESH V PH DBuy65.76K$21.581.42M
2026-08-10PATEL DINESH V PH DSell65.76K$149.119.81M
2026-08-10PATEL DINESH V PH DSell65.76K$21.581.42M
2026-06-23Waddill William D.Buy9.00K$16.54148.86K
2026-06-23Waddill William D.Sell9.00K$117.941.06M
2026-06-23Waddill William D.Sell9.00K$16.54148.86K
2026-06-10Waddill William D.Buy6.00K$16.5499.24K
2026-06-10Waddill William D.Buy3.00K$11.8035.40K
2026-06-10Waddill William D.Sell6.00K$16.5499.24K
2026-06-10Waddill William D.Sell9.00K$107.68969.12K
2026-06-10Waddill William D.Sell3.00K$11.8035.40K
2026-05-29Waddill William D.Buy9.00K$11.80106.20K
2026-05-29Waddill William D.Sell9.00K$99.64896.76K
2026-05-29Waddill William D.Sell9.00K$11.80106.20K
2026-05-12PATEL DINESH V PH DBuy75.00K$21.581.62M
2026-05-12PATEL DINESH V PH DSell75.00K$100.127.51M
2026-05-12PATEL DINESH V PH DSell75.00K$21.581.62M
2026-05-08Giraudo BryanSell5.13K$100.00513.00K
2026-05-08Giraudo BryanSell6.00K$100.00600.00K
2026-05-07Giraudo BryanBuy12.00K$6.9883.76K
2026-05-07Giraudo BryanBuy24.00K$6.45154.80K
2026-05-07Giraudo BryanSell36.00K$100.143.61M
2026-05-07Giraudo BryanSell12.00K$100.071.20M
2026-05-07Giraudo BryanSell12.00K$6.9883.76K
2026-05-07Giraudo BryanSell24.00K$6.45154.80K
2026-04-23PATEL DINESH V PH DSell1.46K——
2026-04-20Ali AsifSell1.75K$105.47184.57K
2026-03-26MOLINA ARTURO MDBuy15.00K$8.04120.60K
2026-03-26MOLINA ARTURO MDSell15.00K$104.791.57M
2026-03-26MOLINA ARTURO MDSell15.00K$8.04120.60K
2026-03-26SELICK HAROLD EBuy24.00K$12.88309.12K
2026-03-26SELICK HAROLD ESell24.00K$105.002.52M
2026-03-26SELICK HAROLD ESell24.00K$12.88309.12K
2026-03-26Ali AsifBuy5.26K$12.1764.08K
2026-03-26Ali AsifBuy19.50K$19.19374.20K
2026-03-26Ali AsifSell24.77K$104.242.58M
2026-03-26Ali AsifSell19.50K$19.19374.20K
2026-03-26Ali AsifSell5.26K$12.1764.08K
2026-03-25PATEL DINESH V PH DBuy54.64K$8.58468.82K
2026-03-25PATEL DINESH V PH DSell54.64K$101.005.52M
2026-03-25PATEL DINESH V PH DSell54.64K$8.58468.82K
2026-03-24PATEL DINESH V PH DBuy59$8.58506
2026-03-24PATEL DINESH V PH DSell59$8.58506
2026-03-23PATEL DINESH V PH DSell50.00K——
2026-02-17Williams Lewis TBuy18.00K$10.84195.12K
2026-02-17Williams Lewis TSell18.00K$82.421.48M
2026-02-17Williams Lewis TBuy18.00K$10.84195.12K
2026-02-06Waddill William D.Buy20.00K$8.31166.20K
2026-02-06Waddill William D.Sell20.00K$83.681.67M
2026-02-06Waddill William D.Sell20.00K$8.31166.20K
2026-01-27PATEL DINESH V PH DBuy4.07K$21.5887.79K
2026-01-27PATEL DINESH V PH DSell4.07K$83.19338.42K
2026-01-27PATEL DINESH V PH DSell4.07K$21.5887.79K
2026-01-27Ali AsifBuy12.00K$12.17146.04K
2026-01-27Ali AsifBuy16.00K$19.19307.04K
2026-01-27Ali AsifSell28.00K$83.132.33M
2026-01-27Ali AsifSell18.20K$83.141.51M
2026-01-27Ali AsifSell16.00K$19.19307.04K
2026-01-27Ali AsifSell12.00K$12.17146.04K
2026-01-27MOLINA ARTURO MDBuy5.00K$8.0440.20K
2026-01-27MOLINA ARTURO MDSell5.00K$82.00410.00K
2026-01-27MOLINA ARTURO MDSell5.00K$8.0440.20K
2026-01-26PATEL DINESH V PH DBuy14.21K$21.58306.54K
2026-01-26PATEL DINESH V PH DBuy10.69K$4.2144.98K
2026-01-26PATEL DINESH V PH DSell10.69K$84.00897.54K
2026-01-26PATEL DINESH V PH DSell14.21K$84.051.19M
2026-01-26PATEL DINESH V PH DSell14.21K$21.58306.54K
2026-01-26PATEL DINESH V PH DSell10.69K$4.2144.98K
2026-01-26MOLINA ARTURO MDSell5.00K$82.28411.40K
2026-01-26MOLINA ARTURO MDSell5.00K$8.0440.20K
2026-01-23PATEL DINESH V PH DBuy19.32K$4.2181.32K
2026-01-23PATEL DINESH V PH DSell19.32K$84.591.63M
2026-01-23PATEL DINESH V PH DSell6.00K——
2026-01-23PATEL DINESH V PH DSell19.32K$4.2181.32K
2026-01-23MOLINA ARTURO MDSell13.15K$82.421.08M
2026-01-20MOLINA ARTURO MDSell9.51K$82.48784.71K
2026-01-20PATEL DINESH V PH DSell34.44K$82.482.84M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 358, holders +24 vs prior quarter. Ownership 115.84%.

HolderSharesChangeChange %Value
BLACKROCK, INC.10.31M528.47K+5.40%1.26B
FARALLON CAPITAL MANAGEMENT, L.L.C.6.35M00.00%778.25M
RTW INVESTMENTS, LP5.06M2.12K+0.04%620.40M
VANGUARD PORTFOLIO MANAGEMENT LLC3.63M148.09K+4.25%444.88M
WELLINGTON MANAGEMENT GROUP LLP3.42M-182.86K-5.08%418.83M
UBS GROUP AG3.40M-1.78M-34.35%416.68M
STATE STREET CORP3.32M204.81K+6.57%407.16M
VANGUARD CAPITAL MANAGEMENT LLC2.85M47.50K+1.69%349.77M
JOHNSON & JOHNSON2.45M00.00%300.22M
INVESCO LTD.2.34M176.00K+8.13%286.92M
PRICE T ROWE ASSOCIATES INC /MD/2.15M484.17K+29.07%263.51M
JUPITER TOPCO LLC2.13M2.13MNew261.04M
GEODE CAPITAL MANAGEMENT, LLC1.74M71.84K+4.30%213.48M
WOODLINE PARTNERS LP1.41M00.00%173.35M
BANK OF AMERICA CORP /DE/1.32M29.06K+2.24%162.36M
JENNISON ASSOCIATES LLC1.15M79.67K+7.43%141.17M
PERCEPTIVE ADVISORS LLC981.88K-249.00K-20.23%120.36M
ADAR1 CAPITAL MANAGEMENT, LLC960.86K-33.26K-3.35%117.78M
MORGAN STANLEY905.99K-112.23K-11.02%111.06M
ALYESKA INVESTMENT GROUP, L.P.889.30K296.10K+49.92%109.01M
HOOD RIVER CAPITAL MANAGEMENT LLC882.74K53.45K+6.45%108.21M
GOLDMAN SACHS GROUP INC812.85K33.91K+4.35%99.64M
DRIEHAUS CAPITAL MANAGEMENT LLC731.05K10.12K+1.40%89.61M
CLEARBRIDGE INVESTMENTS, LLC725.34K103.52K+16.65%88.91M
FMR LLC672.19K10.19K+1.54%82.40M

Earnings and financials

Protagonist Therapeutics, Inc. (PTGX) trades at $141.40, with a market cap of $9.15B and a trailing P/E of 115.20. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
020063000309250002310002862800027357000265810006000000043443300046016000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Protagonist Therapeutics (PTGX) Financials: Revenue & Earnings

PTGX$141.40+0.28 +0.20%

$9.15B

Market Cap

115.20

P/E

30.12

Forward P/E

55

Score

Price History